Cerasorb® Foam products are resorbable, osteoconductive and cancellous bone-like bone regeneration materials prepared from β-tricalcium phosphate (β-TCP) and porcine collagen for filling and bridging degenerative or traumatic bone defects.
The matrix structure supports the three-dimensional regeneration of bone tissue.
In contact with vital bone, the synthetic, bioactive ceramic material
is resorbed by the body over a period of months and is simultaneously replaced by local, autologous bone.
Cerasorb® Foam is radiopaque.
Main uses and indications
Oromaxillofacial surgery and dentistry
Filling and reconstruction of two-walled and multi-walled non-infected bone defects, e.g.:
Defects following extirpation of bone cysts
Atrophied alveolar ridge augmentation
Sinus floor elevation (subantral augmentation)
Filling of alveolar defects following tooth extraction for alveolar ridge preservation
Filling of extraction defects to create an implant bed
Filling of two-walled or multi-walled bone pockets plus bifurcation and trifurcation defects
Defects following surgical tooth removal of impacted teeth or corrective osteotomy
Other, multi-walled bone defects of the alveolar ridge and bones of the face.
General bone surgery
Filling, bridging and/or reconstruction of non-infected bone defects
Plastic reconstruction of damaged bone regions
Bone fusion, e.g. spinal fusion
Filling of intervertebral implants
Limitations on use
Acute and chronic infections in the operative field (soft tissue infections; inflammatory, bacterial bone diseases; osteomyelitis).
For patients receiving antibiotic therapy, it is at the user’s discretion whether to employ Cerasorb® Foam based on a benefit/ risk analysis.
Severe metabolic disorders, such as severe, uncontrolled or poorly controlled diabetes
Metabolic or systemic bone diseases which impair bone or wound healing
Disorders of calcium metabolism
Steroid treatment
Drugs that interfere with calcium metabolism
Immunosuppressive therapy
Endocrine bone disease
Radiation therapy
Nicotine abuse
Use in the region of an active epiphyseal plate
Significant vascular damage in the region of the implantation site
Insufficient soft tissue coverage
Direct contact with the articular cavity
Known allergies to porcine collagen or other protein allergies
Warning
Cerasorb® Foam cannot assume a load-bearing function. Additional osteosynthetic measures may
be required depending on the nature and localisation of the bone defect to be treated.
The radiopacity of Cerasorb® bone regeneration materials is similar to that of cancellous bone and decreases as resorption increases.
This moderate radiopacity may mask pathological conditions.
Ελληνικά 
